• biliary atresia market to expand significantly by 2034, states delveinsight report | albireo pharma, mirum pharmaceuticals Barchart Wed, 22 Jan 2025 16:31:57 GMT
• constipation clinical trials 2024: fda approvals, medication, openPR Fri, 25 Oct 2024 07:00:00 GMT
• alagille syndrome market forecasted to surge in coming years, openPR Thu, 03 Oct 2024 22:02:00 GMT
• albireo pharmaceuticals | biotechnology | the pharmaletter The Pharma Letter Tue, 09 Jul 2024 03:27:03 GMT
• albireo pharma, inc. (nasdaq:albo): when will it breakeven? Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
• wall street analysts predict an 184% upside in albireo pharma (albo): here's what you should know Yahoo News UK Fri, 21 Jun 2024 16:34:28 GMT
• albo - albireo reports second quarter 2019 financial results br.ADVFN.com Fri, 14 Jun 2024 13:33:29 GMT
• genfit gets accelerated approval for new rare liver disease drug The Pharma Letter Tue, 11 Jun 2024 07:00:00 GMT
• is adial pharmaceuticals, inc. (adil) outperforming other medical stocks this year? Yahoo Canada Shine On Wed, 29 May 2024 10:41:18 GMT
• albireo pharma (albo) reports q4 loss, tops revenue estimates Yahoo News Australia Wed, 29 May 2024 04:25:00 GMT
• is adial pharmaceuticals, inc. (adil) outperforming other medical stocks this year? Yahoo Canada Shine On Sun, 26 May 2024 12:46:33 GMT
• is adial pharmaceuticals, inc. (adil) outperforming other medical stocks this year? Yahoo Canada Shine On Sat, 25 May 2024 11:41:56 GMT
• did albireo pharma's (nasdaq:albo) share price deserve to gain 81%? Yahoo Movies Canada Wed, 22 May 2024 00:11:16 GMT
• albireo pharma (albo) reports q4 loss, tops revenue estimates Yahoo News Australia Sat, 18 May 2024 03:32:00 GMT
• is a surprise coming for albireo pharma (albo) this earnings season? Yahoo Singapore News Mon, 06 May 2024 14:41:00 GMT
• albireo pharma (albo) soars 14.4%: is further upside left in the stock? Yahoo Movies UK Mon, 06 May 2024 07:09:12 GMT
• how many albireo pharma, inc. (nasdaq:albo) shares do institutions own? Yahoo Movies Canada Sun, 05 May 2024 13:57:11 GMT
• albireo pharma (albo) soars 14.4%: is further upside left in the stock? Yahoo Movies UK Fri, 03 May 2024 14:11:22 GMT
• albireo (albo) gets fda nod for rare liver disease drug Yahoo Movies UK Mon, 29 Apr 2024 16:53:48 GMT
• albireo (albo) gets fda nod for rare liver disease drug Yahoo Movies UK Sat, 27 Apr 2024 16:53:48 GMT
• how many albireo pharma, inc. (nasdaq:albo) shares do institutions own? Yahoo Movies Canada Mon, 22 Apr 2024 11:37:52 GMT
• ileal sodium & bile acid cotransporter market rapid growth at deep value price :albireo pharma inc, cj healthcare ... Post Production Buyers Guide Wed, 17 Apr 2024 08:07:29 GMT
• how many albireo pharma, inc. (nasdaq:albo) shares do institutions own? Yahoo Movies Canada Tue, 16 Apr 2024 14:07:22 GMT
• Mirum scores 2nd FDA nod for rare liver disease drug Livmarli, this one to treat PFIC Fierce Pharma Wed, 13 Mar 2024 07:00:00 GMT
• mirum expands label for rare liver disease drug, serving up more competition for ipsen's bylvay Endpoints News Wed, 13 Mar 2024 07:00:00 GMT
• biliary atresia market to register incremental growth during the forecast period (2023-2032), asserts delveinsight | albireo pharm... The Globe and Mail Tue, 12 Mar 2024 07:00:00 GMT
• biliary atresia market | cagr, emerging drugs, marketed therapies, key companies, and epidemiology A spasso con Smith Thu, 29 Feb 2024 10:40:26 GMT
• alagille syndrome market size, share, growth, trends, forecast by 2024-2031 | albireo pharma, ipsen pharma, EIN News Wed, 17 Jan 2024 14:01:00 GMT
• chronic idiopathic constipation treatment market rapid growth at deep value price :bayer ag, albireo pharma, inc ... Artrocker Wed, 10 Jan 2024 13:02:19 GMT
• ileal sodium/bile acid cotransporter market report analysis, research studies |albireo pharma inc, cj healthcare ... Rough Cut Reviews Tue, 02 Jan 2024 04:59:03 GMT
• pruritus ani medicine market is expected to record the massive growth | abbvie (allergan plc), albireo pharma ... salisburyandstonehenge Wed, 13 Dec 2023 07:02:15 GMT
• pruritus type skin diseases medicine market to witness massive growth by 2030 | abbvie (allergan plc), albireo ... salisburyandstonehenge Wed, 13 Dec 2023 07:02:10 GMT
• ileal sodium/bile acid cotransporter market to expand with significant cagr by 2029 |albireo pharma inc, cj ... Artrocker Tue, 12 Dec 2023 10:39:18 GMT
• ileal sodium/bile acid cotransporter market will touch new level in upcoming year | albireo pharma inc, cj ... salisburyandstonehenge Fri, 01 Dec 2023 09:10:31 GMT
• pruritus ani medicine market developments 2029 |abbvie (allergan plc), albireo pharma, astellas pharma inc., cipla ... Argyle Report Tue, 21 Nov 2023 12:08:27 GMT
• countries ileal sodium/bile acid cotransporter industry scope – albireo pharma inc, cj health care corp ... Argyle Report Mon, 20 Nov 2023 04:49:36 GMT
• sindrome di alagille: l'ema nega la designazione orfana a odevixibat Osservatorio Malattie Rare Sat, 11 Nov 2023 08:00:00 GMT
• odevixibat safe for alagille syndrome based on hepatic changes AJMC.com Managed Markets Network Wed, 08 Nov 2023 08:00:00 GMT
• ileal sodium/bile acid cotransporter market 2023: comprehensive study by top key players albireo pharma inc, cj ... Argyle Report Mon, 06 Nov 2023 17:39:34 GMT
• mbx biosciences announces appointment of michelle graham as chief human resources officer GlobeNewswire Wed, 01 Nov 2023 07:00:00 GMT
• primary sclerosing cholangitis market to grow at a tremendous ... PR Newswire Tue, 31 Oct 2023 07:00:00 GMT
• ipsen updates on e.u. marketing authorisation application for ... Ipsen Mon, 23 Oct 2023 06:43:40 GMT
• life biosciences grows up: a q&a with jerry mclaughlin Life Science Leader Magazine Mon, 02 Oct 2023 07:00:00 GMT
• ipsen announces change in r&d leadership: howard mayer to retire ... Ipsen Fri, 01 Sep 2023 07:00:00 GMT
• catalent announces governance enhancements and new ... Business Wire Tue, 29 Aug 2023 07:00:00 GMT
• amicus therapeutics appoints simon harford as chief financial ... GlobeNewswire Mon, 21 Aug 2023 07:00:00 GMT
• Bylvay (odevixibat) for the Treatment of Pruritus, USA Clinical Trials Arena Fri, 18 Aug 2023 07:00:00 GMT
• fda grants approval to ipsen for ultra-rare bone disease drug MM+M Online Thu, 17 Aug 2023 07:00:00 GMT
• orphan drugs market size to surpass usd 368.43 billion in 2030 ... Yahoo Finance Tue, 01 Aug 2023 07:00:00 GMT
• the galien foundation announces 2023 prix galien usa nominees ... PR Newswire Thu, 27 Jul 2023 07:00:00 GMT
• ipsen delivers solid h1 2023 results and upgrades its full-year ... Ipsen Thu, 27 Jul 2023 07:00:00 GMT
• mirum snaps up 2 liver disease drugs from travere for up to $445m FiercePharma Tue, 18 Jul 2023 07:00:00 GMT
• lessons learned from the intense back-and-forth over a $1b acquisition Timmerman Report Mon, 10 Jul 2023 07:00:00 GMT
• as-0369 effectively prevents cholemic nephropathy in models BioWorld Online Mon, 03 Jul 2023 07:00:00 GMT
• seven things life sciences buyers and sellers should know about ... Sidley Austin LLP Thu, 29 Jun 2023 07:00:00 GMT
• global constipation treatment market report 2023-2030 - lucrative ... Yahoo Finance Fri, 23 Jun 2023 07:00:00 GMT
• Key Components and Trends of CVRs in Life Sciences Public M&A Deals The Harvard Law School Forum on Corporate Governance Fri, 16 Jun 2023 07:00:00 GMT
• bylvay backers buoyed as new nod brings relief for chronic illness The Pharma Letter Wed, 14 Jun 2023 07:00:00 GMT
• After Albireo buyout, Ipsen's Bylvay picks up new FDA-approved use Fierce Pharma Tue, 13 Jun 2023 07:00:00 GMT
• ipsen itching drug scratches off a second fda approval in rare ... MedCity News Tue, 13 Jun 2023 07:00:00 GMT
• metabolic dysfunction-associated fatty liver disease in people living ... Nature.com Tue, 06 Jun 2023 07:00:00 GMT
• go or no go? key fda decisions for argenx and regeneron Evaluate Pharma Wed, 31 May 2023 07:00:00 GMT
• risk stratified monitoring for methotrexate toxicity in immune ... The BMJ Tue, 30 May 2023 07:00:00 GMT
• anatomy of a cvr: a primer on the key components and trends of ... Sidley Austin LLP Fri, 19 May 2023 07:00:00 GMT
• regulatory tracker: ucb's zilbrysq picks up eu nod to treat ... FiercePharma Wed, 17 May 2023 15:16:51 GMT
• regulatory tracker: amid glp-1 probe, eu asks companies for more ... FiercePharma Wed, 17 May 2023 15:16:51 GMT
• ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance Ipsen Thu, 27 Apr 2023 07:00:00 GMT
• law firm covington opens boston office, chasing life sciences work Reuters Tue, 18 Apr 2023 07:00:00 GMT
• ocelot bio appoints lise kjems, m.d., ph.d., as chief medical officer Business Wire Tue, 18 Apr 2023 07:00:00 GMT
• pfizer's fortunes overshadow first-quarter dealmaking Evaluate Pharma Tue, 11 Apr 2023 07:00:00 GMT
• a proteo-transcriptomic map of non-alcoholic fatty liver disease ... Nature.com Mon, 10 Apr 2023 07:00:00 GMT
• ipsen hunts for targets with $4.4 billion to spend, ceo says Bloomberg Thu, 06 Apr 2023 07:00:00 GMT
• rare disease player bridgebio draws buyout interest: report FiercePharma Tue, 28 Mar 2023 07:00:00 GMT
• biomarkers for staging fibrosis and non-alcoholic steatohepatitis in ... The Lancet Mon, 20 Mar 2023 07:00:00 GMT
• semaglutide 2·4 mg once weekly in patients with non-alcoholic ... The Lancet Thu, 16 Mar 2023 07:00:00 GMT
• Ipsen concludes purchase of Albireo Pharma Pharmaceutical Technology Fri, 03 Mar 2023 08:00:00 GMT
• ipsen réussit son opa sur albireo et étend son portefeuille en ... Investir Fri, 03 Mar 2023 08:00:00 GMT
• ipsen completes acquisition of albireo, expanding the scope of its rare disease portfolio Ipsen Thu, 02 Mar 2023 08:00:00 GMT
• bristol myers dodges one $6.4b celgene buyout cvr suit, but the battle is far from over FiercePharma Thu, 02 Mar 2023 08:00:00 GMT
• is albireo pharma (albo) stock outpacing its medical peers this year? Yahoo Singapore News Wed, 01 Mar 2023 08:00:00 GMT
• ipsen extends expiration date of tender offer for albireo pharma, inc. to 1 march 2023 Ipsen Wed, 22 Feb 2023 06:17:54 GMT
• fda grants june 15, 2023 pdufa date to albireo for bylvay® in alagille syndrome GlobeNewswire Tue, 14 Feb 2023 08:00:00 GMT
• biotech went through its ipo boom. now the shakeout is underway Bloomberg Mon, 13 Feb 2023 08:00:00 GMT
• business development remains top priority for ipsen insights.citeline.com Fri, 10 Feb 2023 08:00:00 GMT
• strong full-year 2022 results and guidance for 2023 | ipsen global Ipsen Thu, 09 Feb 2023 08:00:00 GMT
• buyout from ipsen: do not underestimate the value of albireo's contingent value right Seeking Alpha Thu, 02 Feb 2023 08:00:00 GMT
• buyout from ipsen: do not underestimate value of albireo's contingent value right Seeking Alpha Thu, 02 Feb 2023 08:00:00 GMT
• ey eyes comeback for biopharma m&a Genetic Engineering & Biotechnology News Tue, 31 Jan 2023 08:00:00 GMT
• ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price a... Business Wire Tue, 24 Jan 2023 08:00:00 GMT
• How a buyer's sudden withdrawal gave Ipsen a chance to fight for Albireo Fierce Pharma Tue, 24 Jan 2023 08:00:00 GMT
• Failed deal, bidding war paved the way for Ipsen’s $952M rare disease buyout Endpoints News Tue, 24 Jan 2023 08:00:00 GMT
• how a sudden withdrawal led to m&a bidding war for albireo FiercePharma Tue, 24 Jan 2023 08:00:00 GMT
• cincor, albireo each received higher bids in 2022 before this month's m&a deals BioCentury Tue, 24 Jan 2023 08:00:00 GMT
• can the fda keep the momentum going for rare disease drug approvals? Pharmaceutical Technology Mon, 23 Jan 2023 08:00:00 GMT
• primary biliary cirrhosis clinical trial pipeline insights featuring 22 ... GlobeNewswire Mon, 23 Jan 2023 08:00:00 GMT
• ipsen's onivyde turns in positive results in pancreatic cancer FiercePharma Fri, 20 Jan 2023 08:00:00 GMT
• jpm23: ipsen ceo happy to take on big pharma in rare diseases but says gene therapy is rife with risk FiercePharma Wed, 18 Jan 2023 08:00:00 GMT
• ipsen ceo steers clear of gene therapy despite rare disease push FiercePharma Wed, 18 Jan 2023 08:00:00 GMT
• stock watch: j.p. morgan conference, big splash news and stock prices Scrip Mon, 16 Jan 2023 08:00:00 GMT
• tanking biotech stocks will mean a big year for deals. who could benefit. Barron's Sat, 14 Jan 2023 08:00:00 GMT
• StockWatch: Shares Double for Targets of 3 Buyout Deals Announced at JPM Genetic Engineering and Biotechnology News Fri, 13 Jan 2023 08:00:00 GMT
• ipsen to acquire rare disease specialist albireo in deal worth over $950m PMLiVE Fri, 13 Jan 2023 08:00:00 GMT
• albireo pharma stock: elucidating the ipsen buyout (rating upgrade) (nasdaq:albo) Seeking Alpha Tue, 10 Jan 2023 08:00:00 GMT
• albireo pharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price a... Business Wire Tue, 10 Jan 2023 08:00:00 GMT
• JPM23: Ipsen scoops up liver disease specialist Albireo for $952M Fierce Pharma Mon, 09 Jan 2023 08:00:00 GMT
• Orrick Advises Ipsen on Acquisition of Liver Disease Treatment Innovator Albireo orrick.com Mon, 09 Jan 2023 08:00:00 GMT
• Twin biggies rattle JPM takeover field: AZ signs $1.8B deal with Cincor, Chiesi to buy Amryt; Ipsen snatches up Albireo, too BioWorld MedTech Mon, 09 Jan 2023 08:00:00 GMT
• In separate deals, European drug makers buying local biotech firms CinCor and Albireo The Boston Globe Mon, 09 Jan 2023 08:00:00 GMT
• france-based ipsen acquires albireo pharma enriching its rare disease portfolio, pipeline Yahoo Finance Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to acquire albireo accelerating growth in rare disease with treatments for several pediatric liver diseases Business Wire Mon, 09 Jan 2023 08:00:00 GMT
• at #jpm23, another rare disease buyout as ipsen acquires albireo for $952m Endpoints News Mon, 09 Jan 2023 08:00:00 GMT
• billion dollar buy adds albireo to ipsen's list of strategic takeovers The Pharma Letter Mon, 09 Jan 2023 08:00:00 GMT
• cvrs address risks in billion-dollar az-cincor, ipsen-albireo deals BioCentury Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to buy liver disease drugmaker for $952m The Business Journals Mon, 09 Jan 2023 08:00:00 GMT
• m&a monday: astrazeneca leads way as 3 pharmas splash out $3.5b in deals MedCity News Mon, 09 Jan 2023 08:00:00 GMT
• ipsen to acquire albireo - growth in rare disease | ipsen global Ipsen Mon, 09 Jan 2023 08:00:00 GMT
• ipsen pays $952m to acquire albireo and liver disease med bylvay FiercePharma Mon, 09 Jan 2023 08:00:00 GMT
• shareholder alert: ademi llp investigates whether albireo pharma, inc. has obtained a fair price in its transaction with ... Marketscreener.com Mon, 09 Jan 2023 08:00:00 GMT
Albireo Pharma, Inc(NASDAQ:ALBO) 
Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transpor...
Website: http://www.albireopharma.com
Full Time Employees: 90 (May 2021)
Sector: Healthcare
Industry: Biotechnology